Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz ...

Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication ...

ImmunityBio IBRX has entered a new phase as a commercial-stage immunotherapy developer. The company’s near-term trajectory is ...

Stryker workers in Memphis, along with colleagues across the globe, woke up Wednesday to find themselves abruptly cut off from the digital tools that keep the medical technology giant running. Email, ...

Building on lessons from an internal agent SDK called “Breadboard”, the agent step is not just another node in a workflow — ...

Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd ...

SMX’s solution is designed for deployment through strategic logistics and infrastructure partners, enabling white-label ...

The takeaway is simple: Broken processes do not get fixed on April 14. They get fixed every day in the way you track expenses ...

A German logistics firm exploits gaps in European law to ship contraband to Russia. We know because we followed their illicit route from a Berlin supermarket to Moscow.

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

This week, Cisco patches and hacks. Trojanized app targeted Israelis. Bye-bye, Tycoon 2FA. Also bye-bye LeakBase. A ...

Risk-off sentiment dragged the ASX healthcare sector lower this week, headlined by Immutep’s plunge after scrapping a Phase III trial ... Read More The post Scott Power: ASX healthcare sector reels ...